EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Mast cells in cardiovascular disease: Fibrosis, angiogenesis and atherogenesis

Gabriel Bueno, Ilze Bot, Anish A Kanhai, Roberta Stilhano, Peter Libby, Guido R Y De Meyer, Leonardo Martin

Progress in Cardiovascular Diseases · 2026

DOI: 10.1016/j.pcad.2025.11.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Progress in Cardiovascular Diseases, 2026. Verfasst von Gabriel Bueno und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiological Sciences, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil. Hauptthemen laut MEDLINE: Mast Cells, Atherosclerosis, Neovascularization, Pathologic, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Antwerp, Netherlands Heart Foundation, Horizon Europe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mast cells have emerged as pivotal regulators of cardiovascular physiology and pathology, influencing key processes including fibrosis, angiogenesis, tissue regeneration, and atherosclerosis. This review synthesizes findings from 110 studies to delineate the multifaceted roles of mast cells across these domains. Historically associated with allergic responses, growing evidence now underscores their substantial contribution to the progression of cardiovascular diseases. In fibrotic remodeling, mast cells facilitate extracellular matrix deposition and fibroblast activation through the release of pro-fibrotic mediators such as tryptase and chymase. In the context of angiogenesis, mast cells enhance endothelial proliferation and vascular permeability, predominantly through VEGF-driven signaling pathways. Although the role of mast cells in cardiac regeneration remains underexplored, current evidence suggests a context-dependent function in modulating stem cell dynamics and inflammatory microenvironments. Additionally, mast cells can participate in the pathogenesis of atherosclerosis by promoting lipid accumulation, vascular inflammation, and plaque destabilization. Collectively, these findings highlight mast cells as integral components of cardiovascular disease mechanisms. Therapeutic targeting of mast cell-derived mediators and signaling pathways, through stabilizers, enzyme inhibitors, or selective modulators, represents an avenue worthy of investigation for clinical intervention. Future studies should refine these strategies, aiming to mitigate mast cell-driven pathogenesis while preserving their physiological roles in tissue homeostasis and immune defense.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mast CellsAtherosclerosisNeovascularization, PathologicCardiovascular DiseasesCardiovascular SystemHumansAnimalsFibrosisSignal TransductionAngiogenesis

Stichwörter der Autor:innen

AngiogenesisAtherosclerosisCardiac fibrosisCardiac regenerationMast cells

Autor:innen und Institutionen

  • Department of Physiological Sciences, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.
  • Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands.
  • Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Pharmaceutical Sciences, Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium; Infla-Med Centre of Excellence, University of Antwerp, Belgium.
  • Department of Pharmaceutical Sciences, Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium; Infla-Med Centre of Excellence, University of Antwerp, Belgium. Electronic add…

Förderung

  • University of Antwerp
  • Netherlands Heart Foundation
  • Horizon Europe
  • Fonds Wetenschappelijk Onderzoek
  • Agence Nationale de la Recherche
  • Vlaamse regering

Zitieren

APA

Bueno, G., Bot, I., Kanhai, A. A., Stilhano, R., Libby, P., De Meyer, G. R. Y., & Martin, L. (2026). Mast cells in cardiovascular disease: Fibrosis, angiogenesis and atherogenesis. Progress in Cardiovascular Diseases. https://doi.org/10.1016/j.pcad.2025.11.007

Vancouver

Bueno G, Bot I, Kanhai AA, Stilhano R, Libby P, De Meyer GRY, et al. Mast cells in cardiovascular disease: Fibrosis, angiogenesis and atherogenesis. Progress in Cardiovascular Diseases. 2026. doi:10.1016/j.pcad.2025.11.007

BibTeX
@article{Bueno2026,
  author = {Bueno, Gabriel and Bot, Ilze and Kanhai, Anish A and Stilhano, Roberta and Libby, Peter and De Meyer, Guido R Y and Martin, Leonardo},
  title = {Mast cells in cardiovascular disease: Fibrosis, angiogenesis and atherogenesis},
  journal = {Progress in Cardiovascular Diseases},
  year = {2026},
  doi = {10.1016/j.pcad.2025.11.007}
}
Kostenlos starten →